Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Lineage Cell Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Lineage Cell Therapeutics Inc. September 6, 202394.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 23, 2023 | Insight Molecular Diagnostics Inc. | Grant or award | +20,000 | — | — |
| Jun 14, 2023 | Insight Molecular Diagnostics Inc. | Open-market purchase | +30,000 | $0.21 | $6,300 |
| Dec 1, 2022 | Lineage Cell Therapeutics Inc. | Gift | −25,000 | — | — |
Questions about Alfred D. Kingsley
What boards is Alfred D. Kingsley on?
Alfred D. Kingsley sits on the boards of Insight Molecular Diagnostics Inc. and Lineage Cell Therapeutics Inc.
How long has Alfred D. Kingsley served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.